Paul A. Brough
Impact in
-
- Computational Drug Discovery Methods
-
- thermodynamics and calorimetric analyses
Papers in
-
- Heat shock proteins research 9
- ATP Synthase and ATPases Research 4
- Ion channel regulation and function 2
- Protein Structure and Dynamics 2
- Nicotinic Acetylcholine Receptors Study 2
-
- Computational Drug Discovery Methods 8
- Co-authors
- Paul Workman (4 shared papers)Edward McDonald (3 shared papers)Andrew J. Massey (6 shared papers)Lisa Wright (5 shared papers)Stephen D. Roughley (3 shared papers)A.E. Surgenor (3 shared papers)Xavier Barril (4 shared papers)Roderick E. Hubbard (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Molecular Cancer Therapeutics (2 papers)Current Topics in Medicinal Chemistry (2 papers)The Analyst (1 paper)
- Partner nations
- United KingdomCanadaSwitzerland
In The Last Decade
Paul A. Brough
19 papers receiving 783 citations
Peers
Comparison fields: 5 of 71
- Computational Theory and Mathematics 212
- Physical and Theoretical Chemistry 86
- Molecular Biology 545
- Organic Chemistry 198
- Toxicology 17
Countries citing papers authored by Paul A. Brough
This map shows the geographic impact of Paul A. Brough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Brough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Brough more than expected).
Fields of papers citing papers by Paul A. Brough
This network shows the impact of papers produced by Paul A. Brough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Brough. The network helps show where Paul A. Brough may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul A. Brough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 176 | |
| 2 | 2006 | 122 | |
| 3 | Targeting Hsp90 for the treatment of cancer. | 2006 | 85 |
| 4 | 2005 | 66 | |
| 5 | 2005 | 58 | |
| 6 | 2014 | 51 | |
| 7 | 2010 | 50 | |
| 8 | 2014 | 50 | |
| 9 | 2008 | 29 | |
| 10 | 1995 | 28 | |
| 11 | 2011 | 21 | |
| 12 | 1996 | 18 | |
| 13 | 1993 | 16 | |
| 14 | 2024 | 11 | |
| 15 | 1994 | 10 | |
| 16 | 1995 | 7 | |
| 17 | 1998 | 6 | |
| 18 | 1992 | 2 | |
| 19 | NVP-AUY922 / VER-52296: A novel 3,4 diarylisoxazole Hsp90 chaperone inhibitor discovered via structure-based drug design | 2007 | 1 |
About Paul A. Brough
Paul A. Brough is a scholar working on Molecular Biology, Computational Theory and Mathematics, Organic Chemistry, Cellular and Molecular Neuroscience and Environmental Chemistry, having authored 19 papers that have together received 807 indexed citations. Recurring topics across this work include Heat shock proteins research (9 papers), Computational Drug Discovery Methods (8 papers), ATP Synthase and ATPases Research (4 papers), Ion channel regulation and function (2 papers), Protein Structure and Dynamics (2 papers), Marine Toxins and Detection Methods (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers) and thermodynamics and calorimetric analyses (2 papers). The work is most often cited by research in Computational Theory and Mathematics (212 citations), Physical and Theoretical Chemistry (86 citations), Molecular Biology (545 citations), Organic Chemistry (198 citations) and Toxicology (17 citations). Paul A. Brough has collaborated with scholars based in United Kingdom, Canada and Switzerland. Frequent co-authors include Paul Workman, Edward McDonald, Andrew J. Massey, Lisa Wright, Stephen D. Roughley, A.E. Surgenor, Xavier Barril, Roderick E. Hubbard, Keith Jones and Joseph Schoepfer. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, Current Topics in Medicinal Chemistry and The Analyst.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.